{"count": 21, "results": [{"_id": "20673352", "pmid": 20673352, "pmcid": "PMC2945124", "title": "Simvastatin attenuates ventilator-induced lung injury in mice", "journal": "Crit Care", "authors": ["Müller HC", "Hellwig K", "Rosseau S", "Tschernig T", "Schmiedl A", "Gutbier B", "Schmeck B", "Hippenstiel S", "Peters H", "Morawietz L", "Suttorp N", "Witzenrath M"], "date": "2010-01-01T00:00:00Z", "doi": "10.1186/cc9209", "meta_date_publication": "2010", "meta_volume": "14", "meta_issue": "4", "meta_pages": "R143", "score": 50084.88, "text_hl": "...@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ attenuated @<m>DISEASE_Vascular_System_Injuries</m> @DISEASE_MESH:D057772 @@@endothelial injury@@@ in ventilated mice", "citations": {"NLM": "Müller HC, Hellwig K, Rosseau S, Tschernig T, Schmiedl A, Gutbier B, Schmeck B, Hippenstiel S, Peters H, Morawietz L, Suttorp N, Witzenrath M. Simvastatin attenuates ventilator-induced lung injury in mice Crit Care. 2010;14(4):R143. PMID: 20673352", "BibTeX": "@article{20673352, title={Simvastatin attenuates ventilator-induced lung injury in mice}, author={Müller HC and Hellwig K and Rosseau S and Tschernig T and Schmiedl A and Gutbier B and Schmeck B and Hippenstiel S and Peters H and Morawietz L and Suttorp N and Witzenrath M}, journal={Crit Care}, volume={14}, number={4}, pages={R143}}"}}, {"_id": "15520323", "pmid": 15520323, "title": "Simvastatin prevents vascular hyporeactivity during inflammation.", "journal": "Circulation", "authors": ["Pleiner J", "Schaller G", "Mittermayer F", "Zorn S", "Marsik C", "Polterauer S", "Kapiotis S", "Wolzt M"], "date": "2004-11-23T00:00:00Z", "doi": "10.1161/01.CIR.0000147774.90396.ED", "meta_date_publication": "2004 Nov 23", "meta_volume": "110", "meta_issue": "21", "meta_pages": "3349-54", "score": 50083.406, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ prevents @<m>DISEASE_Vascular_System_Injuries</m> @DISEASE_MESH:D057772 @@@vascular hyporeactivity@@@ during @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammation@@@.", "citations": {"NLM": "Pleiner J, Schaller G, Mittermayer F, Zorn S, Marsik C, Polterauer S, Kapiotis S, Wolzt M. Simvastatin prevents vascular hyporeactivity during inflammation. Circulation. 2004 Nov 23;110(21):3349-54. PMID: 15520323", "BibTeX": "@article{15520323, title={Simvastatin prevents vascular hyporeactivity during inflammation.}, author={Pleiner J and Schaller G and Mittermayer F and Zorn S and Marsik C and Polterauer S and Kapiotis S and Wolzt M}, journal={Circulation}, volume={110}, number={21}, pages={3349-54}}"}}, {"_id": "30982448", "pmid": 30982448, "title": "Intraluminal Delivery of Simvastatin Attenuates Intimal Hyperplasia After Arterial Injury.", "journal": "Vasc Endovascular Surg", "authors": ["Helkin A", "Bruch D", "Wilson DR", "Gruessner AC", "Bader RR", "Maier KG", "Gahtan V"], "date": "2019-07-01T00:00:00Z", "doi": "10.1177/1538574419833224", "meta_date_publication": "2019 Jul", "meta_volume": "53", "meta_issue": "5", "meta_pages": "379-386", "score": 50075.016, "text_hl": "Intraluminal Delivery of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ Attenuates @DISEASE_Hyperplasia @DISEASE_MESH:D006965 @@@Intimal Hyperplasia@@@ After @<m>DISEASE_Vascular_System_Injuries</m> @DISEASE_MESH:D057772 @@@Arterial Injury@@@.", "citations": {"NLM": "Helkin A, Bruch D, Wilson DR, Gruessner AC, Bader RR, Maier KG, Gahtan V. Intraluminal Delivery of Simvastatin Attenuates Intimal Hyperplasia After Arterial Injury. Vasc Endovascular Surg. 2019 Jul;53(5):379-386. PMID: 30982448", "BibTeX": "@article{30982448, title={Intraluminal Delivery of Simvastatin Attenuates Intimal Hyperplasia After Arterial Injury.}, author={Helkin A and Bruch D and Wilson DR and Gruessner AC and Bader RR and Maier KG and Gahtan V}, journal={Vasc Endovascular Surg}, volume={53}, number={5}, pages={379-386}}"}}, {"_id": "20031817", "pmid": 20031817, "title": "Statin cost-effectiveness in the United States for people at different vascular risk levels.", "journal": "Circ Cardiovasc Qual Outcomes", "authors": ["Heart Protection Study Collaborative Group"], "date": "2009-03-01T00:00:00Z", "doi": "10.1161/CIRCOUTCOMES.108.808469", "meta_date_publication": "2009 Mar", "meta_volume": "2", "meta_issue": "2", "meta_pages": "65-72", "score": 50069.004, "text_hl": "For an average of 5 years, allocation to @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ reduced the estimated US costs of hospitalizations for @<m>DISEASE_Vascular_System_Injuries</m> @DISEASE_MESH:D057772 @@@vascular@@@ events by approximately 20% (95% CI, 15 to 24) in the different subcategories of participants studied. ", "citations": {"NLM": "Heart Protection Study Collaborative Group. Statin cost-effectiveness in the United States for people at different vascular risk levels. Circ Cardiovasc Qual Outcomes. 2009 Mar;2(2):65-72. PMID: 20031817", "BibTeX": "@article{20031817, title={Statin cost-effectiveness in the United States for people at different vascular risk levels.}, author={Heart Protection Study Collaborative Group}, journal={Circ Cardiovasc Qual Outcomes}, volume={2}, number={2}, pages={65-72}}"}}, {"_id": "10636283", "pmid": 10636283, "title": "Effects of hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin on smooth muscle cell proliferation in vitro and neointimal formation in vivo after vascular injury.", "journal": "J Am Coll Cardiol", "authors": ["Indolfi C", "Cioppa A", "Stabile E", "Di Lorenzo E", "Esposito G", "Pisani A", "Leccia A", "Cavuto L", "Stingone AM", "Chieffo A", "Capozzolo C", "Chiariello M"], "date": "2000-01-01T00:00:00Z", "doi": "10.1016/s0735-1097(99)00526-4", "meta_date_publication": "2000 Jan", "meta_volume": "35", "meta_issue": "1", "meta_pages": "214-21", "score": 50062.844, "text_hl": "Effects of hydroxymethylglutaryl coenzyme A reductase inhibitor @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on smooth muscle cell proliferation in vitro and @DISEASE_Neointima @DISEASE_MESH:D058426 @@@neointimal formation@@@ in vivo after @<m>DISEASE_Vascular_System_Injuries</m> @DISEASE_MESH:D057772 @@@vascular injury@@@.", "citations": {"NLM": "Indolfi C, Cioppa A, Stabile E, Di Lorenzo E, Esposito G, Pisani A, Leccia A, Cavuto L, Stingone AM, Chieffo A, Capozzolo C, Chiariello M. Effects of hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin on smooth muscle cell proliferation in vitro and neointimal formation in vivo after vascular injury. J Am Coll Cardiol. 2000 Jan;35(1):214-21. PMID: 10636283", "BibTeX": "@article{10636283, title={Effects of hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin on smooth muscle cell proliferation in vitro and neointimal formation in vivo after vascular injury.}, author={Indolfi C and Cioppa A and Stabile E and Di Lorenzo E and Esposito G and Pisani A and Leccia A and Cavuto L and Stingone AM and Chieffo A and Capozzolo C and Chiariello M}, journal={J Am Coll Cardiol}, volume={35}, number={1}, pages={214-21}}"}}, {"_id": "15076215", "pmid": 15076215, "title": "Simvastatin enhances the regeneration of endothelial cells via VEGF secretion in injured arteries.", "journal": "J Cardiovasc Pharmacol", "authors": ["Matsuno H", "Takei M", "Hayashi H", "Nakajima K", "Ishisaki A", "Kozawa O"], "date": "2004-03-01T00:00:00Z", "doi": "10.1097/00005344-200403000-00002", "meta_date_publication": "2004 Mar", "meta_volume": "43", "meta_issue": "3", "meta_pages": "333-40", "score": 50060.645, "text_hl": "We here report that the carotid arterial blood flow after @<m>DISEASE_Vascular_System_Injuries</m> @DISEASE_MESH:D057772 @@@endothelial injury@@@ in @SPECIES_10026 @@@hamsters@@@ treated with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ was restored, in contrast to the situation in nontreated @SPECIES_10026 @@@hamsters@@@. ", "citations": {"NLM": "Matsuno H, Takei M, Hayashi H, Nakajima K, Ishisaki A, Kozawa O. Simvastatin enhances the regeneration of endothelial cells via VEGF secretion in injured arteries. J Cardiovasc Pharmacol. 2004 Mar;43(3):333-40. PMID: 15076215", "BibTeX": "@article{15076215, title={Simvastatin enhances the regeneration of endothelial cells via VEGF secretion in injured arteries.}, author={Matsuno H and Takei M and Hayashi H and Nakajima K and Ishisaki A and Kozawa O}, journal={J Cardiovasc Pharmacol}, volume={43}, number={3}, pages={333-40}}"}}, {"_id": "23817506", "pmid": 23817506, "title": "Effect of simvastatin on physiological and biological outcomes in patients undergoing esophagectomy: a randomized placebo-controlled trial.", "journal": "Ann Surg", "authors": ["Shyamsundar M", "McAuley DF", "Shields MO", "MacSweeney R", "Duffy MJ", "Johnston JR", "McGuigan J", "Backman JT", "Calfee CS", "Matthay MM", "Griffiths MJ", "McDowell C", "Elborn SJ", "OʼKane CM"], "date": "2014-01-01T00:00:00Z", "doi": "10.1097/SLA.0b013e31829d686b", "meta_date_publication": "2014 Jan", "meta_volume": "259", "meta_issue": "1", "meta_pages": "26-31", "score": 50059.992, "text_hl": "CONCLUSIONS: In this proof of concept study, pretreatment with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ in esophagectomy decreased biomarkers of @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammation@@@ as well as pulmonary epithelial and systemic @<m>DISEASE_Vascular_System_Injuries</m> @DISEASE_MESH:D057772 @@@endothelial injury@@@.", "citations": {"NLM": "Shyamsundar M, McAuley DF, Shields MO, MacSweeney R, Duffy MJ, Johnston JR, McGuigan J, Backman JT, Calfee CS, Matthay MM, Griffiths MJ, McDowell C, Elborn SJ, OʼKane CM. Effect of simvastatin on physiological and biological outcomes in patients undergoing esophagectomy: a randomized placebo-controlled trial. Ann Surg. 2014 Jan;259(1):26-31. PMID: 23817506", "BibTeX": "@article{23817506, title={Effect of simvastatin on physiological and biological outcomes in patients undergoing esophagectomy: a randomized placebo-controlled trial.}, author={Shyamsundar M and McAuley DF and Shields MO and MacSweeney R and Duffy MJ and Johnston JR and McGuigan J and Backman JT and Calfee CS and Matthay MM and Griffiths MJ and McDowell C and Elborn SJ and OʼKane CM}, journal={Ann Surg}, volume={259}, number={1}, pages={26-31}}"}}, {"_id": "18791454", "pmid": 18791454, "title": "Amelioration of human allograft arterial injury by atorvastatin or simvastatin correlates with reduction of interferon-gamma production by infiltrating T cells.", "journal": "Transplantation", "authors": ["Yi T", "Rao DA", "Tang PC", "Wang Y", "Cuchara LA", "Bothwell AL", "Colangelo CM", "Tellides G", "Pober JS", "Lorber MI"], "date": "2008-09-15T00:00:00Z", "doi": "10.1097/TP.0b013e318183eefa", "meta_date_publication": "2008 Sep 15", "meta_volume": "86", "meta_issue": "5", "meta_pages": "719-27", "score": 50057.438, "text_hl": "Amelioration of @SPECIES_9606 @@@human@@@ allograft @<m>DISEASE_Vascular_System_Injuries</m> @DISEASE_MESH:D057772 @@@arterial injury@@@ by @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@ or @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ correlates with reduction of @GENE_IFNG @GENE_3458 @@@interferon-gamma@@@ production by infiltrating T cells.", "citations": {"NLM": "Yi T, Rao DA, Tang PC, Wang Y, Cuchara LA, Bothwell AL, Colangelo CM, Tellides G, Pober JS, Lorber MI. Amelioration of human allograft arterial injury by atorvastatin or simvastatin correlates with reduction of interferon-gamma production by infiltrating T cells. Transplantation. 2008 Sep 15;86(5):719-27. PMID: 18791454", "BibTeX": "@article{18791454, title={Amelioration of human allograft arterial injury by atorvastatin or simvastatin correlates with reduction of interferon-gamma production by infiltrating T cells.}, author={Yi T and Rao DA and Tang PC and Wang Y and Cuchara LA and Bothwell AL and Colangelo CM and Tellides G and Pober JS and Lorber MI}, journal={Transplantation}, volume={86}, number={5}, pages={719-27}}"}}, {"_id": "12114036", "pmid": 12114036, "title": "MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.", "journal": "Lancet", "authors": ["Heart Protection Study Collaborative Group"], "date": "2002-07-06T00:00:00Z", "doi": "10.1016/S0140-6736(02)09327-3", "meta_date_publication": "2002 Jul 6", "meta_volume": "360", "meta_issue": "9326", "meta_pages": "7-22", "score": 50057.152, "text_hl": "Hence, among the many types of high-risk individual studied, 5 years of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ would prevent about 70-100 people per 1000 from suffering at least one of these major @<m>DISEASE_Vascular_System_Injuries</m> @DISEASE_MESH:D057772 @@@vascular@@@ events (and longer treatment should produce further benefit). ", "citations": {"NLM": "Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002 Jul 6;360(9326):7-22. PMID: 12114036", "BibTeX": "@article{12114036, title={MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.}, author={Heart Protection Study Collaborative Group}, journal={Lancet}, volume={360}, number={9326}, pages={7-22}}"}}, {"_id": "27993685", "pmid": 27993685, "title": "Simvastatin inhibits homocysteine-induced CRP generation via interfering with the ROS-p38/ERK1/2 signal pathway in rat vascular smooth muscle cells.", "journal": "Vascul Pharmacol", "authors": ["Pang X", "Si J", "Xu S", "Li Y", "Liu J"], "date": "2017-01-01T00:00:00Z", "doi": "10.1016/j.vph.2016.12.001", "meta_date_publication": "2017 Jan", "meta_volume": "88", "meta_issue": "", "meta_pages": "42-47", "score": 50054.957, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ inhibits @CHEMICAL_Homocysteine @CHEMICAL_MESH:D006710 @@@homocysteine@@@-induced @GENE_CRP @GENE_25419 @@@CRP@@@ generation via interfering with the @CHEMICAL_Reactive_Oxygen_Species @CHEMICAL_MESH:D017382 @@@ROS@@@-@GENE_MAPK14 @GENE_81649 @@@p38@@@/@GENE_MAPK3 @GENE_50689;116590 @@@ERK1/2@@@ signal pathway in @SPECIES_10116 @@@rat@@@ @<m>DISEASE_Vascular_System_Injuries</m> @DISEASE_MESH:D057772 @@@vascular@@@ smooth muscle cells.", "citations": {"NLM": "Pang X, Si J, Xu S, Li Y, Liu J. Simvastatin inhibits homocysteine-induced CRP generation via interfering with the ROS-p38/ERK1/2 signal pathway in rat vascular smooth muscle cells. Vascul Pharmacol. 2017 Jan;88():42-47. PMID: 27993685", "BibTeX": "@article{27993685, title={Simvastatin inhibits homocysteine-induced CRP generation via interfering with the ROS-p38/ERK1/2 signal pathway in rat vascular smooth muscle cells.}, author={Pang X and Si J and Xu S and Li Y and Liu J}, journal={Vascul Pharmacol}, volume={88}, pages={42-47}}"}}]}